Why is Caris Life Sciences stock rallying today?
Caris Life Sciences (CRIS) stock rose 6.6% in pre-market trading, bouncing from its 200-day moving average near $21.68. The company reported Q3 2026 revenue of $275.4M, up 27% YoY, and EPS of $0.05, beating estimates. Analysts raised price targets, with an average of $31.18. The Nasdaq Composite is also higher, supporting healthcare stocks.
